Cargando…
The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells
Plasma cell leukemia (PCL) is a rare and aggressive plasma cell dyscrasia that may appear as de-novo leukemia (pPCL) or on the basis of a pre-existing multiple myeloma (MM), called secondary plasma cell leukemia (sPCL). In this prospective study, we have applied a broad panel of FISH probes in 965 n...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869452/ https://www.ncbi.nlm.nih.gov/pubmed/35203419 http://dx.doi.org/10.3390/biomedicines10020209 |
_version_ | 1784656501017673728 |
---|---|
author | Papadhimitriou, Stefanos I. Terpos, Evangelos Liapis, Konstantinos Pavlidis, Dimitrios Marinakis, Theodoros Kastritis, Efstathios Dimopoulos, Meletios-Athanasios Tsitsilonis, Ourania E. Kostopoulos, Ioannis V. |
author_facet | Papadhimitriou, Stefanos I. Terpos, Evangelos Liapis, Konstantinos Pavlidis, Dimitrios Marinakis, Theodoros Kastritis, Efstathios Dimopoulos, Meletios-Athanasios Tsitsilonis, Ourania E. Kostopoulos, Ioannis V. |
author_sort | Papadhimitriou, Stefanos I. |
collection | PubMed |
description | Plasma cell leukemia (PCL) is a rare and aggressive plasma cell dyscrasia that may appear as de-novo leukemia (pPCL) or on the basis of a pre-existing multiple myeloma (MM), called secondary plasma cell leukemia (sPCL). In this prospective study, we have applied a broad panel of FISH probes in 965 newly diagnosed MM (NDMM) and 44 PCL cases of both types to reveal the particular cytogenetic differences among the three plasma cell dyscrasias. In order to evaluate the frequency and patterns of clonal evolution, the same FISH panel was applied both at diagnosis and at the time of first relapse for 81 relapsed MM patients and both at MM diagnosis and during sPCL transformation for the 19 sPCL cases described here. pPCL was characterized by frequent MYC translocations and t(11;14) with a 11q13 breakpoint centered on the MYEOV gene, not commonly seen in MM. sPCL had a higher number of FISH abnormalities and was strongly associated with the presence of del(17p13), either acquired at the initial MM stage or as a newly acquired lesion upon leukemogenesis in the context of the apparent clonal evolution observed in sPCL. In clinical terms, sPCL showed a shorter overall survival than pPCL with either standard or high-risk (t(4;14) and/or t(14;16) and/or del(17p13) and/or ≥3 concomitant aberrations) abnormalities (median 5 months vs. 21 and 11 months respectively, p < 0.001), suggesting a prognostic stratification based on cytogenetic background. These observations proved relevant in the NDMM setting, where higher levels of circulating plasma cells (CPCs) were strongly associated with high-risk cytogenetics (median frequency of CPCs: 0.11% of peripheral blood nucleated cells for high-risk vs. 0.007% for standard-risk NDMM, p < 0.0001). Most importantly, the combined evaluation of CPCs (higher or lower than a cut-off of 0.03%), together with patients’ cytogenetic status, could be used for an improved prognostic stratification of NDMM patients. |
format | Online Article Text |
id | pubmed-8869452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88694522022-02-25 The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells Papadhimitriou, Stefanos I. Terpos, Evangelos Liapis, Konstantinos Pavlidis, Dimitrios Marinakis, Theodoros Kastritis, Efstathios Dimopoulos, Meletios-Athanasios Tsitsilonis, Ourania E. Kostopoulos, Ioannis V. Biomedicines Article Plasma cell leukemia (PCL) is a rare and aggressive plasma cell dyscrasia that may appear as de-novo leukemia (pPCL) or on the basis of a pre-existing multiple myeloma (MM), called secondary plasma cell leukemia (sPCL). In this prospective study, we have applied a broad panel of FISH probes in 965 newly diagnosed MM (NDMM) and 44 PCL cases of both types to reveal the particular cytogenetic differences among the three plasma cell dyscrasias. In order to evaluate the frequency and patterns of clonal evolution, the same FISH panel was applied both at diagnosis and at the time of first relapse for 81 relapsed MM patients and both at MM diagnosis and during sPCL transformation for the 19 sPCL cases described here. pPCL was characterized by frequent MYC translocations and t(11;14) with a 11q13 breakpoint centered on the MYEOV gene, not commonly seen in MM. sPCL had a higher number of FISH abnormalities and was strongly associated with the presence of del(17p13), either acquired at the initial MM stage or as a newly acquired lesion upon leukemogenesis in the context of the apparent clonal evolution observed in sPCL. In clinical terms, sPCL showed a shorter overall survival than pPCL with either standard or high-risk (t(4;14) and/or t(14;16) and/or del(17p13) and/or ≥3 concomitant aberrations) abnormalities (median 5 months vs. 21 and 11 months respectively, p < 0.001), suggesting a prognostic stratification based on cytogenetic background. These observations proved relevant in the NDMM setting, where higher levels of circulating plasma cells (CPCs) were strongly associated with high-risk cytogenetics (median frequency of CPCs: 0.11% of peripheral blood nucleated cells for high-risk vs. 0.007% for standard-risk NDMM, p < 0.0001). Most importantly, the combined evaluation of CPCs (higher or lower than a cut-off of 0.03%), together with patients’ cytogenetic status, could be used for an improved prognostic stratification of NDMM patients. MDPI 2022-01-19 /pmc/articles/PMC8869452/ /pubmed/35203419 http://dx.doi.org/10.3390/biomedicines10020209 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Papadhimitriou, Stefanos I. Terpos, Evangelos Liapis, Konstantinos Pavlidis, Dimitrios Marinakis, Theodoros Kastritis, Efstathios Dimopoulos, Meletios-Athanasios Tsitsilonis, Ourania E. Kostopoulos, Ioannis V. The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells |
title | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells |
title_full | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells |
title_fullStr | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells |
title_full_unstemmed | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells |
title_short | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells |
title_sort | cytogenetic profile of primary and secondary plasma cell leukemia: etiopathogenetic perspectives, prognostic impact and clinical relevance to newly diagnosed multiple myeloma with differential circulating clonal plasma cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869452/ https://www.ncbi.nlm.nih.gov/pubmed/35203419 http://dx.doi.org/10.3390/biomedicines10020209 |
work_keys_str_mv | AT papadhimitrioustefanosi thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT terposevangelos thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT liapiskonstantinos thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT pavlidisdimitrios thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT marinakistheodoros thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT kastritisefstathios thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT dimopoulosmeletiosathanasios thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT tsitsilonisouraniae thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT kostopoulosioannisv thecytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT papadhimitrioustefanosi cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT terposevangelos cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT liapiskonstantinos cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT pavlidisdimitrios cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT marinakistheodoros cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT kastritisefstathios cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT dimopoulosmeletiosathanasios cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT tsitsilonisouraniae cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells AT kostopoulosioannisv cytogeneticprofileofprimaryandsecondaryplasmacellleukemiaetiopathogeneticperspectivesprognosticimpactandclinicalrelevancetonewlydiagnosedmultiplemyelomawithdifferentialcirculatingclonalplasmacells |